FEBS Letters · 2002 · 43 citations · 36 references
Life SciencesInfectious DiseasesMicrobiologyInflammationMedical MicrobiologyMicrobial PathogenesisBacterial PathogenesisBacterial ToxinsCytokine BiologyCytokine RegulationToxin ProductionToxin-mediated PathogenesisBacterial Toxin BiologyBacterial Toxin ProductionDisease VirulenceEscherichia ColiInflammatory Cytokine ProductionPathogenesis Of Bacterial ToxinsPore-forming ToxinsShiga Toxins
Shiga toxin-producing Escherichia coli (STEC) is associated with hemolytic uremic syndrome (HUS). Although most clinical isolates of STEC produce hemolysin (called enterohemolysin), the precise role of enterohemolysin in the pathogenesis of STEC infections is unknown. Here we demonstrated that E. coli carrying the cloned enterohemolysin operon (hlyC, A, B, D genes) from an STEC human strain induced the production of interleukin-1beta (IL-1beta) through its mRNA expression but not tumor necrosis factor-alpha from human monocytes. No IL-1beta release was observed with an enterohemolysin (HlyA)-negative, isogenic E. coli strain carrying a mutation in the hlyA gene. The data suggest that enterohemolysin, a pore-forming toxin, induces the production of IL-1beta, which is one of serum risk markers for HUS.
36
Lothar Beutin, Maria Augusta Santos Montenegro, I Orskóv et al. · Journal of Clinical Microbiology · 1989 · 419 citations · Full text
Mary Jacewicz, Henrik Clausen, Edward Nudelman et al. · The Journal of Experimental Medicine · 1986 · 403 citations · Full text